KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Common Equity (2016 - 2025)

Historic Common Equity for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $353.7 million.

  • Biolife Solutions' Common Equity rose 868.86% to $353.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.7 million, marking a year-over-year increase of 868.86%. This contributed to the annual value of $348.9 million for FY2024, which is 333.05% up from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Common Equity is $353.7 million, which was up 868.86% from $347.2 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Common Equity peaked at $489.3 million during Q3 2021, and registered a low of $208.8 million during Q1 2021.
  • Over the past 5 years, Biolife Solutions' median Common Equity value was $352.6 million (recorded in 2025), while the average stood at $370.8 million.
  • In the last 5 years, Biolife Solutions' Common Equity surged by 32731.31% in 2021 and then plummeted by 2477.93% in 2023.
  • Over the past 5 years, Biolife Solutions' Common Equity (Quarter) stood at $478.0 million in 2021, then decreased by 23.82% to $364.2 million in 2022, then decreased by 7.28% to $337.7 million in 2023, then rose by 3.33% to $348.9 million in 2024, then grew by 1.38% to $353.7 million in 2025.
  • Its last three reported values are $353.7 million in Q3 2025, $347.2 million for Q2 2025, and $352.6 million during Q1 2025.